Solicitor General D. John Sauer is urging the Supreme Court to deny AstraZeneca’s petition to hear the constitutionality of ...

Pharmaceutical companies are getting a fresh look for a range of drugs in development, plus a regulatory reprieve.

BostonGene, the developer of an AI foundation model for tumor and immune biology, has entered a strategic collaboration with ...

J&J's diversified pharma and MedTech strength stacks up against AstraZeneca's oncology-led growth as investors weigh stability versus faster expansion.

WASHINGTON (AP) — AstraZeneca on Friday became the second major pharmaceutical manufacturer to announce it had agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the ...